Item 7.01 Regulation FD Disclosure.

On January 11, 2023, Veradigm Inc., a Delaware corporation (the "Company"), issued a press release regarding the Company's new share repurchase program and financial guidance for fiscal 2023. A copy of the press release is attached hereto as Exhibit 99.1.

Also on January 11, 2023, the Company will present at the 2023 J.P. Morgan Healthcare conference. A copy of the Company's presentation is attached hereto as Exhibit 99.2. The Company intends to use this presentation at other investor conferences.

The information furnished pursuant to this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit Number Exhibit Description
99.1             Press release issued by Veradigm Inc. on January 11, 2023
99.2             Copy of Veradigm Inc. presentation slides
104            Cover Page Interactive Data File (embedded within the Inline XBRL
               document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses